• FREE priority shipping on all orders $200+
  • Same-day shipping on orders placed by 4 PM ET
For laboratory research use only. Not for human or veterinary use.

Ships next business day.

Compound overviews

GHK-Cu: what the published research actually examines

GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine. The published literature on it is largely review, cell-model and animal work.

Research Peptides Labs editorial team. Published September 23, 2026. About 4 minutes.

For laboratory research use only. Not for human or veterinary use, consumption, diagnostic use, or therapeutic application.

Identity

GHK is a tripeptide with the sequence glycyl-L-histidyl-L-lysine, catalogued by PubChem under compound identifier 73587 with its structure, formula and synonyms 1. GHK-Cu is that tripeptide in complex with copper.

The distinction between the free tripeptide and its copper complex runs through the literature, and papers are not always explicit about which form a given experiment used. It is worth checking when reading any individual study.

Where the sequence comes from

GHK is a naturally occurring human peptide sequence rather than a designed molecule, which is why review articles describe it as a natural modulator rather than an engineered one 3. That origin is the reason it has been studied at all: it was found in human material first and characterized afterwards.

Its association with tissue-remodeling processes was described in the older literature and is the thread most later work follows 4.

What the literature examines

The bulk of published GHK work sits at the level of mechanism. A substantial part of it is gene-expression work, examining which transcripts change in cell systems exposed to the peptide, and one widely cited review is built around exactly that body of gene data 2.

A second strand describes the sequence as acting on more than one cellular pathway at once, which is how it is framed in review work on skin-regeneration models 3. A third, older strand connects it to tissue-remodeling processes 4.

Read together, the literature is an account of what has been observed in defined experimental systems. It is not an account of outcomes in people, and this article does not present it as one.

The shape of the evidence base

Knowing what kind of study a claim rests on tells you more than the claim itself. The table sets out what is actually in the GHK literature cited here.

Study types in the GHK literature cited in this article
Source typeWhat it contributesWhat it cannot settle
Database record [1]Structure, formula and identifiers for the tripeptideAnything about how the molecule behaves in a system
Gene-data review [2]A synthesis of transcript-level observations in cell systemsWhether those observations carry into a whole organism
Pathway review [3]A summary of the cellular pathways reported across studiesThe size or reliability of any single reported effect
Tissue-remodeling review [4]Historical framing of where the sequence was first studiedCurrent mechanistic detail
Forward-looking review [5]How the field describes the work that remains to be doneAnything established, since it is framed as potential

Four of the five sources are review articles. Reviews are useful for orientation and poor as primary evidence, because they summarize other people's experiments and inherit the limits of those experiments.

What has not been established

The most recent of the reviews cited here is titled around the potential of the peptide, and it frames the work that way deliberately, with the primary material sitting in cell and animal models 5. Potential is the correct word for a literature at that stage.

  • No outcome in humans is described in this article, and none should be inferred from it.
  • Mechanistic observations in cell systems are not statements about whole organisms.
  • Review articles do not add evidence; they organize what already exists.
  • Nothing here describes what the material supplied on this site does, because that has not been studied here.

That list is the honest summary. The literature is real, it is largely mechanistic, and it stops well short of the conclusions the sequence is often used to imply elsewhere.

Our GHK-Cu listing

The card below reads its name, vial content, price and availability from the live catalog record, and its document link appears because an approved document is on file for that listing. The article on reading a certificate of analysis explains what such a document does and does not establish.

References

  1. 1. PubChem CID 73587, glycyl-L-histidyl-L-lysine (2026)
  2. 2. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (2018)
  3. 3. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (2015)
  4. 4. The human tri-peptide GHK and tissue remodeling (2008)
  5. 5. The potential of GHK as an anti-aging peptide (2020)

Back to the Research Library